JP2012508698A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012508698A5 JP2012508698A5 JP2011535880A JP2011535880A JP2012508698A5 JP 2012508698 A5 JP2012508698 A5 JP 2012508698A5 JP 2011535880 A JP2011535880 A JP 2011535880A JP 2011535880 A JP2011535880 A JP 2011535880A JP 2012508698 A5 JP2012508698 A5 JP 2012508698A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- peptide
- composition
- amino acid
- variant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200801601 | 2008-11-17 | ||
| DKPA200801601 | 2008-11-17 | ||
| PCT/DK2009/050304 WO2010054667A1 (en) | 2008-11-17 | 2009-11-17 | Il-4-derived peptides for modulation of the chronic inflammatory response and treatment of autoimmune diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012508698A JP2012508698A (ja) | 2012-04-12 |
| JP2012508698A5 true JP2012508698A5 (enExample) | 2012-12-13 |
| JP5750373B2 JP5750373B2 (ja) | 2015-07-22 |
Family
ID=41510516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011535880A Active JP5750373B2 (ja) | 2008-11-17 | 2009-11-17 | 慢性炎症性応答の調節および自己免疫疾患の処置のためのｉｌ−４由来ペプチド |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8546321B2 (enExample) |
| EP (1) | EP2365983B1 (enExample) |
| JP (1) | JP5750373B2 (enExample) |
| CN (1) | CN102216323B (enExample) |
| AU (1) | AU2009316076B2 (enExample) |
| BR (1) | BRPI0921717A2 (enExample) |
| CA (1) | CA2743394C (enExample) |
| ES (1) | ES2620437T3 (enExample) |
| IL (1) | IL212962A0 (enExample) |
| NZ (1) | NZ592943A (enExample) |
| RU (1) | RU2542375C2 (enExample) |
| WO (1) | WO2010054667A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2824515C (en) | 2011-01-18 | 2022-09-13 | Bioniz, Llc | Compositions and methods for modulating gamma-c-cytokine activity |
| US9959384B2 (en) | 2013-12-10 | 2018-05-01 | Bioniz, Llc | Methods of developing selective peptide antagonists |
| PT3277722T (pt) | 2015-04-02 | 2021-10-06 | Intervet Int Bv | Anticorpos para recetor alfa da interleucina-4 canina |
| PT3359556T (pt) | 2015-10-09 | 2021-08-30 | Bioniz Llc | Modulação da atividade de citocinas gama-c |
| KR102707650B1 (ko) * | 2017-04-07 | 2024-09-19 | 바이오니즈 테라퓨틱스, 아이엔씨. | 감마-c-사이토카인 활성의 안정한 조절자 |
| KR102095284B1 (ko) | 2017-05-11 | 2020-04-01 | (주)케어젠 | 메토트렉세이트와 펩타이드의 결합체 |
| ES2971898T3 (es) | 2018-02-27 | 2024-06-10 | Univ Der Johannes Gutenberg Univ Mainz | Nuevos compuestos peptídicos obtenidos a partir de IL-4-/IL-13 para el tratamiento o la prevención de enfermeda-des neurodegenerativas o neuroinflamatorias |
| CN111494625B (zh) * | 2018-12-25 | 2022-06-21 | 江苏荃信生物医药股份有限公司 | 用于治疗il-4和/或il-13介导的信号转导相关的疾病的药物组合物 |
| BR112021021878A2 (pt) | 2019-05-03 | 2022-01-18 | Bioniz Llc | Modulação dos efeitos de sinalização da gama-c-citocina para tratamento da alopecia e distúrbios associados |
| JP7724972B2 (ja) * | 2022-01-05 | 2025-08-18 | セロダス アンパーツセルスケープ | 肥満の治療における使用のためのｉｌ－４由来ペプチド |
| US12440535B2 (en) | 2022-04-29 | 2025-10-14 | Serodus Aps | IL-4 derived peptide fragments for use in the treatment of diabetic nephropathy |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05503088A (ja) * | 1989-11-21 | 1993-05-27 | ザ ユニバーシティー オブ メルボルン | 抗炎症用の組成物及び方法 |
| PT96230B (pt) * | 1989-12-20 | 1998-06-30 | Schering Corp | Processo para a producao de um polipeptideo e anticorpos antagonistas da interleuquina-4 humana |
| US6337072B1 (en) * | 1998-04-03 | 2002-01-08 | Hyseq, Inc. | Interleukin-1 receptor antagonist and recombinant production thereof |
| AU776790B2 (en) * | 1999-02-12 | 2004-09-23 | Lexigen Pharmaceuticals Corporation | Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies |
| GB9912350D0 (en) * | 1999-05-26 | 1999-07-28 | European Molecular Biology Lab Embl | Modified cytokine |
| US20030056244A1 (en) * | 2000-05-02 | 2003-03-20 | Ning Huang | Feed additive compositions and methods |
| FR2838444B1 (fr) * | 2002-04-10 | 2016-01-01 | Neovacs | Nouveaux peptides et leur application en therapeutique |
| WO2004096849A2 (en) * | 2003-04-25 | 2004-11-11 | University Of Manitoba | Peptide-based cytokine/chemokine vaccines against allergy |
| US20070207947A1 (en) * | 2003-10-16 | 2007-09-06 | Aplagen Gmbh | Stabilized Peptides |
-
2009
- 2009-11-17 US US13/127,574 patent/US8546321B2/en active Active
- 2009-11-17 NZ NZ592943A patent/NZ592943A/xx not_active IP Right Cessation
- 2009-11-17 JP JP2011535880A patent/JP5750373B2/ja active Active
- 2009-11-17 AU AU2009316076A patent/AU2009316076B2/en not_active Ceased
- 2009-11-17 EP EP09764175.7A patent/EP2365983B1/en active Active
- 2009-11-17 ES ES09764175.7T patent/ES2620437T3/es active Active
- 2009-11-17 CN CN200980145907.4A patent/CN102216323B/zh not_active Expired - Fee Related
- 2009-11-17 WO PCT/DK2009/050304 patent/WO2010054667A1/en not_active Ceased
- 2009-11-17 RU RU2011121971/10A patent/RU2542375C2/ru not_active IP Right Cessation
- 2009-11-17 CA CA2743394A patent/CA2743394C/en active Active
- 2009-11-17 BR BRPI0921717A patent/BRPI0921717A2/pt not_active IP Right Cessation
-
2011
- 2011-05-17 IL IL212962A patent/IL212962A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012508698A5 (enExample) | ||
| Zhang et al. | Interleukin‐17 and ischaemic stroke | |
| AU2024203359A1 (en) | T cell receptors | |
| AU2011298556B2 (en) | Use of interleukin-22 in treating viral hepatitis | |
| EP4370146A2 (en) | Lipidated peptide inhibitors of interleukin-23 receptor | |
| RU2011121971A (ru) | Пептиды-производные ил-4 для модуляции хронического воспалительного ответа и лечения аутоиммунных заболеваний | |
| JP2016518351A5 (enExample) | ||
| CN104066440B (zh) | 白介素-22在治疗和预防神经损伤疾病或神经退行性疾病中的用途 | |
| WO2007047791A2 (en) | Monomeric self-associating fusion polypeptides and therapeutic uses thereof | |
| JP2013513377A5 (enExample) | ||
| CN103501805A (zh) | 调节γ-C-细胞因子活性的组合物及方法 | |
| CN103596584A (zh) | 多取代的胰岛素 | |
| AU2023255027A1 (en) | Modulating gamma-C-cytokine activity | |
| JP2006506942A5 (enExample) | ||
| JP2009112314A5 (enExample) | ||
| RS60053B1 (sr) | Modifikator eksenatida i njegova primena | |
| JP2026035575A (ja) | 長時間作用型インターロイキン－１５融合タンパク質、その調製方法およびその用途 | |
| CA3240982A1 (en) | Peptide inhibitors of interleukin-23 receptor | |
| JP2011528334A5 (enExample) | ||
| JP2009544304A5 (enExample) | ||
| CA3180251A1 (en) | Cytokine conjugates | |
| JP2014515595A5 (enExample) | ||
| JP2015533372A5 (enExample) | ||
| KR102732054B1 (ko) | 신규한 glp-1, gip, 및 글루카곤 수용체 모두에 활성을 갖는 삼중 활성체 및 이를 포함하는 비만의 예방 또는 치료용 약학적 조성물 | |
| JP2008546816A (ja) | エキセンディン４ポリペプチドフラグメントおよびその使用 |